Ibuprofen Market Size Worth USD 112.3 Million by 2028 | CAGR: 2.7%
North America will provide lucrative opportunities for growth based on sales in the ibuprofen market share and will hold a share of 29%.
BANGALORE, INDIA, February 1, 2022 /EINPresswire.com/ -- The global ibuprofen market size is estimated to be worth US$ 96 million in 2022 and is projected to reach US$ 112.3 million by 2028 with a CAGR of 2.7% during the forecast period. Key drivers of the ibuprofen market include the expanding pharmaceutical production and increasing prevalence of chronic diseases such as arthritis, kidney disease, cardiovascular diseases, diabetes, etc.Further, the usage of advanced technologies in drug development is expected to propel the growth of the ibuprofen market in the coming years.
๐๐๐ญ ๐๐๐ญ๐๐ข๐ฅ๐๐ ๐๐๐๐๐-๐๐ ๐ข๐ฆ๐ฉ๐๐๐ญ ๐๐ง๐๐ฅ๐ฒ๐ฌ๐ข๐ฌ ๐จ๐ง ๐ญ๐ก๐ ๐๐ฏ๐๐ฝ๐ฟ๐ผ๐ณ๐ฒ๐ป ๐ ๐ฎ๐ฟ๐ธ๐ฒ๐: https://reports.valuates.com/request/customisation/QYRE-Auto-28E9344/Ibuprofen_Market
๐๐ ๐ฝ๐ฎ๐ป๐ฑ๐ถ๐ป๐ด ๐ฃ๐ต๐ฎ๐ฟ๐บ๐ฎ๐ฐ๐ฒ๐๐๐ถ๐ฐ๐ฎ๐น ๐ฃ๐ฟ๐ผ๐ฑ๐๐ฐ๐๐ถ๐ผ๐ป ๐๐ป๐ฑ ๐๐ป๐ฐ๐ฟ๐ฒ๐ฎ๐๐ถ๐ป๐ด ๐ฃ๐ฟ๐ฒ๐๐ฎ๐น๐ฒ๐ป๐ฐ๐ฒ ๐ข๐ณ ๐๐ต๐ฟ๐ผ๐ป๐ถ๐ฐ ๐๐ถ๐๐ฒ๐ฎ๐๐ฒ๐:
Pharmaceutical companies are increasing production costs and investing heavily in research and development initiatives in order to beat the globalized competition. Ibuprofen is a non-steroidal anti-inflammatory drug that has huge demand and the potential to generate high-profit margins. Moreover, the prevalence of a wide variety of diseases such as cardiovascular disease, diabetes, arthritis, kidney problems among all age groups especially in the older generation is driving the demand for ibuprofen which is used for reducing pain and inflammation. Thus the ever-expanding production base of pharmaceutical companies and universal prevalence of chronic diseases will drive the growth of the ibuprofen market during the forecast period.
๐๐ฑ๐๐ฎ๐ป๐ฐ๐ฒ๐ฑ ๐ง๐ฒ๐ฐ๐ต๐ป๐ผ๐น๐ผ๐ด๐ถ๐ฒ๐ ๐๐ป ๐๐ฟ๐๐ด ๐๐ฒ๐๐ฒ๐น๐ผ๐ฝ๐บ๐ฒ๐ป๐:
The rise in technological advancements in drug discovery will create huge potential for market growth in the future. Researchers are using supercomputing and artificial intelligence for the accurate detection of chemical compounds. This has made the entire drug discovery system more effective and time-saving. Automation, imaging hardware, and software are being used in drug development to facilitate faster identification and enhanced screening. Thus the usage of advanced technologies in drug development will drive the growth of the ibuprofen market during the forecast period.
๐๐ฒ๐ ๐๐ผ๐๐ฟ ๐๐ฎ๐บ๐ฝ๐น๐ฒ ๐๐ผ๐ฑ๐ฎ๐: https://reports.valuates.com/request/sample/QYRE-Auto-28E9344/Ibuprofen_Market
๐๐ฏ๐๐ฝ๐ฟ๐ผ๐ณ๐ฒ๐ป ๐ ๐ฎ๐ฟ๐ธ๐ฒ๐ ๐ฏ๐ ๐ง๐๐ฝ๐ฒ:
Based on type, the USP segment is expected to provide lucrative opportunities for growth in the ibuprofen market share during the forecast period and will hold a share of 65%.
๐๐ฏ๐๐ฝ๐ฟ๐ผ๐ณ๐ฒ๐ป ๐ ๐ฎ๐ฟ๐ธ๐ฒ๐ ๐ฏ๐ ๐๐ฝ๐ฝ๐น๐ถ๐ฐ๐ฎ๐๐ถ๐ผ๐ป:
Based on application, the tablet segment is expected to provide lucrative opportunities for growth in the ibuprofen market share and will hold a share of 46%.
๐๐ฏ๐๐ฝ๐ฟ๐ผ๐ณ๐ฒ๐ป ๐ ๐ฎ๐ฟ๐ธ๐ฒ๐ ๐ฏ๐ ๐ฅ๐ฒ๐ด๐ถ๐ผ๐ป:
Based on region, Asia-pacific will lead on a production basis with China being the largest supplier at a market share of 48% and India at 30%. On the other hand, North America will provide lucrative opportunities for growth based on sales in the ibuprofen market share and will hold a share of 29%. Europe is the second-largest at 26%.
๐ฉ๐ถ๐ฒ๐ ๐๐๐น๐น ๐ฅ๐ฒ๐ฝ๐ผ๐ฟ๐: https://reports.valuates.com/reports/QYRE-Auto-28E9344/ibuprofen
๐๐ผ๐ป๐๐ฒ๐พ๐๐ฒ๐ป๐ฐ๐ฒ ๐ผ๐ณ ๐๐ผ๐๐ถ๐ฑ-๐ญ๐ต ๐ฃ๐ฎ๐ป๐ฑ๐ฒ๐บ๐ถ๐ฐ:
The authors of this study have enlightened the readers on the rise and effect of the Covid-19 outbreak on the development. They have investigated the changes brought about in the demand/supply side, consumption, supply chain, and sales/manufacturing. The readers will get familiar with the measures that have helped the key players to bring the Ibuprofen market back to the pre-covid levels.
๐ง๐ฟ๐ฒ๐ป๐ฑ๐ & ๐ฃ๐ฟ๐ผ๐๐ฝ๐ฒ๐ฐ๐๐:
In this segment of the report, the specialists have delved into the key growth opportunities that are likely to emerge. This will aid the key players to simplify complex issues related to business and frame future strategies to compete in this competitive environment. This section will certainly assist the players to boldly position their business.
๐๐ ๐ง๐๐ฝ๐ฒ
โฃUSP
โฃEP
๐๐ ๐๐ฝ๐ฝ๐น๐ถ๐ฐ๐ฎ๐๐ถ๐ผ๐ป
โฃTablet
โฃCapsule
โฃSuspension
โฃOthers
๐๐ถ๐๐ ๐ผ๐ณ ๐๐ฒ๐ ๐ฃ๐น๐ฎ๐๐ฒ๐ฟ๐
โฃXinhua Pharmaceutical
โฃIOLCP
โฃGranules Biocause
โฃStrides Shasun
โฃBASF
โฃSI Group
โฃXinhua-Perrigo Pharmaceutical
โฃHisoar
๐ฆ๐ถ๐บ๐ถ๐น๐ฎ๐ฟ ๐ฅ๐ฒ๐ฝ๐ผ๐ฟ๐๐:
Ibuprofen API Market: https://reports.valuates.com/market-reports/QYRE-Auto-12X6333/global-ibuprofen-api-sales
Intravenous (IV) Ibuprofen Market: https://reports.valuates.com/market-reports/QYRE-Auto-33Q3518/global-intravenous-iv-ibuprofen
Delta Damascone Market: https://reports.valuates.com/reports/QYRE-Othe-0J465/delta-damascone
Almotriptan Malate API Market: https://reports.valuates.com/market-reports/QYRE-Auto-11Q7767/global-and-japan-almotriptan-malate-api
Choline Fenofibrate API Market: https://reports.valuates.com/market-reports/QYRE-Auto-31K7458/global-and-united-states-choline-fenofibrate-api
Posaconazole API Market: https://reports.valuates.com/market-reports/QYRE-Auto-39S8061/global-posaconazole-api
Famotidine API Market: https://reports.valuates.com/market-reports/QYRE-Auto-17F6223/global-famotidine-api
Sodium Bicarbonate Market: https://reports.valuates.com/market-reports/QYRE-Auto-1625/global-sodium-bicarbonate
Dexlansoprazole API Market: https://reports.valuates.com/market-reports/QYRE-Auto-20V5956/global-dexlansoprazole-api
Valuates Sales
Valuates Reports
+1 425-388-2538
email us here
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
![](https://www.einpresswire.com/tracking/article.gif?t=2&a=SqHhPXtG5Fgl23AI&i=ddmLDxb1W7wjZ7a-)